# FDA Inspection 1270360 - Novo Nordisk Pharmatech A/S - October 24, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmatech-as/3023c778-82c3-4178-9ba3-f0717fb86a93
Source feed: FDA_Inspections

> FDA Inspection 1270360 for Novo Nordisk Pharmatech A/S on October 24, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1270360
- Company Name: Novo Nordisk Pharmatech A/S
- Inspection Date: 2024-10-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1270360 - 2024-10-24](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmatech-as/569e724a-ed6e-40be-86c8-f7060fa1a246)
- [FDA Inspection 1124229 - 2018-10-12](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmatech-as/7b411c8f-ea69-4573-92fc-35bdbfa25c36)
- [FDA Inspection 974523 - 2016-06-03](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-pharmatech-as/ec11c46d-cd8b-4561-a582-136dce5bd395)

Company: https://www.globalkeysolutions.net/companies/novo-nordisk-pharmatech-as/a72dc99f-baa8-4075-88fc-0a7040265dae

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c